Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,874 | -55,523 | -35,220 | -29,604 | -30,861 |
| Depreciation Amortization | 281 | 266 | 285 | 789 | 1,522 |
| Accounts receivable | 0 | 326 | -326 | 0 | 0 |
| Accounts payable and accrued liabilities | -2,950 | -477 | 3,027 | -1,210 | -1,833 |
| Other Working Capital | -5,043 | 1,343 | 487 | 39 | -5,730 |
| Other Operating Activity | -2,314 | 5,146 | 840 | 4,385 | 4,990 |
| Operating Cash Flow | $-36,900 | $-48,919 | $-30,907 | $-25,601 | $-31,912 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 5,328 |
| PPE Investments | N/A | -766 | -80 | N/A | -15 |
| Other Investing Activity | 0 | 0 | 0 | 10,000 | -10,000 |
| Investing Cash Flow | $0 | $-766 | $-80 | $10,000 | $-4,687 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 19,798 |
| Common Stock Issued | 18,253 | 6,733 | 75,299 | 10,388 | 45,785 |
| Other Financing Activity | 0 | 16,844 | 0 | -18,094 | -22,468 |
| Financing Cash Flow | $18,253 | $23,577 | $75,299 | $-7,706 | $43,115 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -1 |
| Beginning Cash Position | 20,843 | 46,951 | 2,639 | 25,946 | 19,431 |
| End Cash Position | 2,196 | 20,843 | 46,951 | 2,639 | 25,946 |
| Net Cash Flow | $-18,647 | $-26,108 | $44,312 | $-23,307 | $6,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,900 | -48,919 | -30,907 | -25,601 | -31,912 |
| Capital Expenditure | 0 | -766 | -80 | 0 | -15 |
| Free Cash Flow | -36,900 | -49,685 | -30,987 | -25,601 | -31,927 |